Internal biliary stenting in orthotopic liver transplantation

Mark W. Johnson, Patricia Thompson, Ann Meehan, Pat Odell, M. Jane Salm, David A. Gerber, Steven L. Zacks, Michael W. Fried, Roshan Shrestha, Jeffrey Fair

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Biliary complications account for significant morbidity in orthotopic liver transplantation (OLT), with a reported incidence ranging from 6% to 47%, and many centers are reassessing the need and options available for stenting the biliary anastomosis. We report on our experience using a 6F Silastic, double-J, ureteral stent as an internal biliary stent in OLT. From October 15, 1995, to September 30, 1998, a total of 99 patients at our institution underwent 108 OLTs. Of these, 77 patients received an end-to-end choledochocholedochostomy over an internal stent. Three patients died within 1 week post-OLT, leaving 74 patients for evaluation (follow-up, 2 to 38 months). Stents were placed transanastomotic and transsphincteric at the time of OLT and secured with a dissolvable suture. At 4 to 6 weeks post-OLT, stents visible within the biliary tree on kidney, ureters, and bladder radiograph were removed endoscopically. Graft and patient survival rates were 92% and 96%, respectively. There were 12 biliary complications (18%): anastomotic leak in 6 patients (9%), anastomotic stricture in 5 patients (7.6%), and stent migration in 1 patient (1.5%). Thirty-two patients (43%) passed the biliary stent without intervention, whereas 42 patients (57%) underwent esophagogastro duodenoscopy (EGD) stent removal at 4 to 6 weeks without incident. Treatment of the complications included percutaneous drainage, endoscopic dilatation with stenting, and/or conversion to Roux-en-Y choledochojejunostomy. The use of the 6 F Silastic, double-J, ureteral stent provides a safe and effective means of stenting the biliary anastomosis in OLT. Major advantages to this method are that it: (1) is completely internal, (2) is biliary decompressive, (3) is radiopaque, (4) can be spontaneously passed, and (5) is easily accessible for EGD extraction.

Original languageEnglish (US)
Pages (from-to)356-361
Number of pages6
JournalLiver Transplantation
Volume6
Issue number3
DOIs
StatePublished - May 2000
Externally publishedYes

Fingerprint

Liver Transplantation
Stents
Duodenoscopy
Choledochostomy
Anastomotic Leak
Biliary Tract
Graft Survival
Ureter
Sutures
Dilatation
Drainage
Pathologic Constriction
Urinary Bladder
Survival Rate
Morbidity
Kidney
Incidence

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Johnson, M. W., Thompson, P., Meehan, A., Odell, P., Salm, M. J., Gerber, D. A., ... Fair, J. (2000). Internal biliary stenting in orthotopic liver transplantation. Liver Transplantation, 6(3), 356-361. https://doi.org/10.1053/lv.2000.5303

Internal biliary stenting in orthotopic liver transplantation. / Johnson, Mark W.; Thompson, Patricia; Meehan, Ann; Odell, Pat; Salm, M. Jane; Gerber, David A.; Zacks, Steven L.; Fried, Michael W.; Shrestha, Roshan; Fair, Jeffrey.

In: Liver Transplantation, Vol. 6, No. 3, 05.2000, p. 356-361.

Research output: Contribution to journalArticle

Johnson, MW, Thompson, P, Meehan, A, Odell, P, Salm, MJ, Gerber, DA, Zacks, SL, Fried, MW, Shrestha, R & Fair, J 2000, 'Internal biliary stenting in orthotopic liver transplantation', Liver Transplantation, vol. 6, no. 3, pp. 356-361. https://doi.org/10.1053/lv.2000.5303
Johnson MW, Thompson P, Meehan A, Odell P, Salm MJ, Gerber DA et al. Internal biliary stenting in orthotopic liver transplantation. Liver Transplantation. 2000 May;6(3):356-361. https://doi.org/10.1053/lv.2000.5303
Johnson, Mark W. ; Thompson, Patricia ; Meehan, Ann ; Odell, Pat ; Salm, M. Jane ; Gerber, David A. ; Zacks, Steven L. ; Fried, Michael W. ; Shrestha, Roshan ; Fair, Jeffrey. / Internal biliary stenting in orthotopic liver transplantation. In: Liver Transplantation. 2000 ; Vol. 6, No. 3. pp. 356-361.
@article{a5edb774d6ad43a591c488fdafea5695,
title = "Internal biliary stenting in orthotopic liver transplantation",
abstract = "Biliary complications account for significant morbidity in orthotopic liver transplantation (OLT), with a reported incidence ranging from 6{\%} to 47{\%}, and many centers are reassessing the need and options available for stenting the biliary anastomosis. We report on our experience using a 6F Silastic, double-J, ureteral stent as an internal biliary stent in OLT. From October 15, 1995, to September 30, 1998, a total of 99 patients at our institution underwent 108 OLTs. Of these, 77 patients received an end-to-end choledochocholedochostomy over an internal stent. Three patients died within 1 week post-OLT, leaving 74 patients for evaluation (follow-up, 2 to 38 months). Stents were placed transanastomotic and transsphincteric at the time of OLT and secured with a dissolvable suture. At 4 to 6 weeks post-OLT, stents visible within the biliary tree on kidney, ureters, and bladder radiograph were removed endoscopically. Graft and patient survival rates were 92{\%} and 96{\%}, respectively. There were 12 biliary complications (18{\%}): anastomotic leak in 6 patients (9{\%}), anastomotic stricture in 5 patients (7.6{\%}), and stent migration in 1 patient (1.5{\%}). Thirty-two patients (43{\%}) passed the biliary stent without intervention, whereas 42 patients (57{\%}) underwent esophagogastro duodenoscopy (EGD) stent removal at 4 to 6 weeks without incident. Treatment of the complications included percutaneous drainage, endoscopic dilatation with stenting, and/or conversion to Roux-en-Y choledochojejunostomy. The use of the 6 F Silastic, double-J, ureteral stent provides a safe and effective means of stenting the biliary anastomosis in OLT. Major advantages to this method are that it: (1) is completely internal, (2) is biliary decompressive, (3) is radiopaque, (4) can be spontaneously passed, and (5) is easily accessible for EGD extraction.",
author = "Johnson, {Mark W.} and Patricia Thompson and Ann Meehan and Pat Odell and Salm, {M. Jane} and Gerber, {David A.} and Zacks, {Steven L.} and Fried, {Michael W.} and Roshan Shrestha and Jeffrey Fair",
year = "2000",
month = "5",
doi = "10.1053/lv.2000.5303",
language = "English (US)",
volume = "6",
pages = "356--361",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Internal biliary stenting in orthotopic liver transplantation

AU - Johnson, Mark W.

AU - Thompson, Patricia

AU - Meehan, Ann

AU - Odell, Pat

AU - Salm, M. Jane

AU - Gerber, David A.

AU - Zacks, Steven L.

AU - Fried, Michael W.

AU - Shrestha, Roshan

AU - Fair, Jeffrey

PY - 2000/5

Y1 - 2000/5

N2 - Biliary complications account for significant morbidity in orthotopic liver transplantation (OLT), with a reported incidence ranging from 6% to 47%, and many centers are reassessing the need and options available for stenting the biliary anastomosis. We report on our experience using a 6F Silastic, double-J, ureteral stent as an internal biliary stent in OLT. From October 15, 1995, to September 30, 1998, a total of 99 patients at our institution underwent 108 OLTs. Of these, 77 patients received an end-to-end choledochocholedochostomy over an internal stent. Three patients died within 1 week post-OLT, leaving 74 patients for evaluation (follow-up, 2 to 38 months). Stents were placed transanastomotic and transsphincteric at the time of OLT and secured with a dissolvable suture. At 4 to 6 weeks post-OLT, stents visible within the biliary tree on kidney, ureters, and bladder radiograph were removed endoscopically. Graft and patient survival rates were 92% and 96%, respectively. There were 12 biliary complications (18%): anastomotic leak in 6 patients (9%), anastomotic stricture in 5 patients (7.6%), and stent migration in 1 patient (1.5%). Thirty-two patients (43%) passed the biliary stent without intervention, whereas 42 patients (57%) underwent esophagogastro duodenoscopy (EGD) stent removal at 4 to 6 weeks without incident. Treatment of the complications included percutaneous drainage, endoscopic dilatation with stenting, and/or conversion to Roux-en-Y choledochojejunostomy. The use of the 6 F Silastic, double-J, ureteral stent provides a safe and effective means of stenting the biliary anastomosis in OLT. Major advantages to this method are that it: (1) is completely internal, (2) is biliary decompressive, (3) is radiopaque, (4) can be spontaneously passed, and (5) is easily accessible for EGD extraction.

AB - Biliary complications account for significant morbidity in orthotopic liver transplantation (OLT), with a reported incidence ranging from 6% to 47%, and many centers are reassessing the need and options available for stenting the biliary anastomosis. We report on our experience using a 6F Silastic, double-J, ureteral stent as an internal biliary stent in OLT. From October 15, 1995, to September 30, 1998, a total of 99 patients at our institution underwent 108 OLTs. Of these, 77 patients received an end-to-end choledochocholedochostomy over an internal stent. Three patients died within 1 week post-OLT, leaving 74 patients for evaluation (follow-up, 2 to 38 months). Stents were placed transanastomotic and transsphincteric at the time of OLT and secured with a dissolvable suture. At 4 to 6 weeks post-OLT, stents visible within the biliary tree on kidney, ureters, and bladder radiograph were removed endoscopically. Graft and patient survival rates were 92% and 96%, respectively. There were 12 biliary complications (18%): anastomotic leak in 6 patients (9%), anastomotic stricture in 5 patients (7.6%), and stent migration in 1 patient (1.5%). Thirty-two patients (43%) passed the biliary stent without intervention, whereas 42 patients (57%) underwent esophagogastro duodenoscopy (EGD) stent removal at 4 to 6 weeks without incident. Treatment of the complications included percutaneous drainage, endoscopic dilatation with stenting, and/or conversion to Roux-en-Y choledochojejunostomy. The use of the 6 F Silastic, double-J, ureteral stent provides a safe and effective means of stenting the biliary anastomosis in OLT. Major advantages to this method are that it: (1) is completely internal, (2) is biliary decompressive, (3) is radiopaque, (4) can be spontaneously passed, and (5) is easily accessible for EGD extraction.

UR - http://www.scopus.com/inward/record.url?scp=0034072650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034072650&partnerID=8YFLogxK

U2 - 10.1053/lv.2000.5303

DO - 10.1053/lv.2000.5303

M3 - Article

C2 - 10827239

AN - SCOPUS:0034072650

VL - 6

SP - 356

EP - 361

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 3

ER -